Total (%) | Severe malaria (%) | Uncomplicated malaria (%) | p | |
---|---|---|---|---|
Number of cases | 190 (100) | 34 (17.9%) | 156 (82.1%) | – |
Mean age (DE) | 32 (13.8) | 35.3 (11.1) | 31.2 (14.3) | NS |
Sex | ||||
Men | 121 (63.7) | 27 (79.4) | 94 (60.3) | 0.04 |
Women | 69 (36.3) | 7 (20.6) | 62 (39.7) | |
Species | ||||
P. falciparum | 122 (64.2) | 27 (79.4) | 95 (60.9) | NS |
P. vivax | 44(23.2) | 4 (11.8) | 40 (25.6) | |
P. ovale | 2 (1.1) | 0 (0) | 2 (1.3) | |
P. malariae | 3 (1.6) | 0 (0) | 3 (1.9) | |
P. spp. | 14 (7.4) | 2 (5.9) | 12 (7.7) | |
Co-infectionsa | 5 (2.6) | 1 (2.9) | 4 (2.6) | |
Positive Immunocromatography (N = 124) | 109 (87.9) | 27 (90) | 82 (85.4) | NS |
Travel destination | ||||
Sub-Saharan Africa | 142 (74.7) | 33 (97.1) | 109 (69.9) | 0.02 |
Indian sub-continent | 46 (24.2) | 1 (2.9) | 45 (28.8) | 0.003 |
Amèrica | 2 (1.1) | 0 (0) | 2 (1.3) | |
Length of trip ≤ 30 days (N = 147) | 39 (26.5) | 10 (29.4) | 29 (18.5) | NS |
Presence of risk factorsb | 8 (4.2) | 0 (0) | 8 (5.1%) | NS |
Immigrant | 164 (86.3) | 25 (73.5) | 139 (89.1) | 0.01 |
Travel reason | ||||
Tourism | 8 (4.2) | 5 (14.7) | 3 (1.9) | |
VFRs | 171 (90) | 25 (73.5) | 146 (93.6) | <0.001 |
Business | 11 (5.8) | 4 (11.8) | 7 (4.5) | |
Prior travel advice | 26 (13.7) | 5 (14.7) | 21 (13.4) | NS |
Chemoprophylaxis | 19 (10) | 4 (11.8) | 15 (9.6) | NS |
Care level | ||||
Primary care | 64 (33.7) | 2 (5.9) | 62 (39.7) | <0.001 |
Emergency area | 34 (17.9) | 3 (8.8) | 31 (19.9) | |
Medicine ward | 87 (45.8) | 24 (70.6) | 63 (40.4) | <0.001 |
ICU | 5 (2.6) | 5 (14.7) | 0 (0) | |
Treatment | ||||
Quinine | 71 (37.4) | 29 (85.3) | 42 (26.9) | <0.001 |
Artemether | 4 (2.1) | 1 (2.9) | 3 (1.9) | |
Atovaquone/Prog. | 62 (32.6) | 2 (5.9) | 60 (38.5) | <0.001 |
Other | 53 (27.9) | 2 (5.9) | 51 (32.7) | |
Sequelae at discharge | 3 (1.6) | 3 (8.8) | 0 (0) | NS |
Favourable clinical evolution (to 30 days) | 190 (100) | 34 (100) | 156 (100) | – |
Mortality | 0 (0) | 0 (0) | 0 (0) | – |